StockData

Niki BioSolutions, Inc. (NIKI) income statement

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.57−0.11 (-6.55%)

Close on Nov 20, 2026Market cap $12.79MP/E –Yield –

Niki BioSolutions, Inc. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-6.2%

Financial strength

Current ratio
0.78
Debt to equity
–
Debt to assets
–
Cash to current liabilities
75.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.55
Dividend yield
–

See a number that looks wrong?